Global Biopsy Devices Market to reach USD 3.36 billion by 2027.Global Biopsy Devices Market is valued approximately USD 2.12 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.8% over the forecast period 2021-2027.
Biopsy is a surgical process of removing tissue from an organ to determine the presence or extent of a disease in the body. These diseases are generally cancerous or inflammatory, that is they spread at a very fast rate if not removed in time. Improvements in the health care infrastructure and increase in the number of cancer patients worldwide are the factors contributing to the market growth. For instance, according to the report published by World Health Organization (WHO), cancer is becoming the leading cause of deaths worldwide. The global cancer occurrence was 14.1 million in the year 2012 and will rise at a whooping rate of 70% in the coming two decades. However, high prices of the devices impede the growth of the market over the forecast period of 2021-2027. Also, advancements in the technology and increasing awareness about diagnosis of such diseases is likely to increase the growth of the market in the forecasting period.

The regional analysis of global Biopsy Devices market when considering for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World has led to the analysis that North America is a significant region across the world in terms of market share owing to establishment of prominent players in the region and high penetration rate of advanced technologies in the market. Whereas Asia Pacific is anticipated to exhibit the highest growth rate over the forecast period 2021-2027. Factors such as improvements in the healthcare infrastructure coupled with increase in the cancer rates in the region would create lucrative growth prospects for the Biopsy Devices market across Asia-Pacific region.

Major market player included in this report are:
Boston Scientific Corporation
CAREFUSION Corporation
DEVICOR Medical Products Inc
DTR Medical
Hologic Inc
C.R. Bard Inc
Cardinal Health Inc
Medtronic plc
Cook medical Inc
MELSUNGEN AG




The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Needle-based biopsy guns
Biopsy guidance systems
Biopsy forceps
Biopsy needles
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027

Target Audience of the Global Biopsy Devices Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors